Pharmacy Operator I - 2nd Shift
Amneal
Summary
Entry-level role within the Pharmacy Department responsible for dispensing ingredients for mixing and granulation. Works under close supervision and required to know SOPs and cGMP.
Job description
Schedule
2nd Shift 3:30pm - 12:00am Monday to Friday
Essential Functions
- Responsible for accurately dispensing all materials as per batch record.
- Records and maintains the production batch records after each batch.
- Reviews and follows the batch records with 100% accuracy.
- Responsible for the pharmacy room to be clean, organized and ready for production.
- Responsible for maintaining inventory and reconciliation of materials.
- Ensures the cleanliness and checks calibration status of all scales, and balances.
Additional Responsibilities
- Other duties as management assigns.
Requirements
- High School or GED General HS Curriculum - Preferred
- less than one year in Pharmaceuticals manufacturing experience
- Required to read, write, and communicate in English. - Intermediate
- High school level math and mechanical skills. - Intermediate
- Flexible to work extended hours when required. - Intermediate
- Ability to work as part of a team with understanding of monthly goals. - Intermediate
- Attention to detail and accuracy. - Intermediate
- This position requires successful completion of an OSHA-compliant Respirator Fit Test.
Benefits
- Health insurance
- Insurance benefits
- 401(k) matching contribution
Company overview
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is a leading American publicly traded pharmaceutical company headquartered in Bridgewater, New Jersey. Founded in 2002 by brothers Chirag and Chintu Patel, the company has grown to become one of the largest and fastest-growing generic pharmaceutical manufacturers in the United States. Amneal operates as an integrated pharmaceutical company focused on developing, manufacturing, and distributing generic, brand, and biosimilar products. With approximately 8,100 employees globally, the company maintains operations across North America, Asia, and Europe. Amneal's business is organized into three main segments: a robust U.S. generics business with over 250 product families, a growing specialty pharmaceuticals division focused on central nervous system disorders and endocrine conditions, and an expanding biosimilars portfolio. The company has established itself as a leader in complex dosage forms and difficult-to-manufacture products, with manufacturing capabilities spanning oral solids, injectables, ophthalmics, liquids, topicals, transdermals, and respiratory devices. Amneal's mission 'We make healthy possible' reflects its commitment to providing affordable access to essential medicines while maintaining high-quality standards across its global operations.